Hikma Pharmaceutical | HIK - Current Liabilities

Stock Price
1,308.00
Daily Change
21.00 1.63%
Monthly
4.89%
Yearly
-33.09%
Q2 Forecast
1,279.62

Hikma Pharmaceutical reported $1.45B in Current Liabilities for its fiscal semester ending in December of 2025.





Current Liabilities Change Date
Almirall EUR 350.64M 52.12M Dec/2025
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Autolus Therapeutics Ltd USD 73.44M 9.63M Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Fresenius EUR 9.56B 1.27B Sep/2025
Galapagos EUR 152.86M 213.7M Dec/2025
Genmab DKK 1.43B 686M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.02B 135.85M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.04B 405M Dec/2025
Orion EUR 560.3M 9.8M Dec/2025
Recordati EUR 1.04B 24.44M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
UCB EUR 4.4B 470M Dec/2025